Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2021 / N 1

Первичный васкулит внутренней сонной, позвоночной артерий и их основных ветвей: роль неоптерина и кальпротектина
М.С. Легенько, Л.А. Калашникова, А.А. Шабалина, Л.А. Добрынина, К.В. Шамтиева, М.В. Костырева, М.В. Древаль, Т.А. Лесных

References

1. Salvarani C, Brown RD Jr, Hunder GG. Adult primary central nervous system vasculitis. The Israel Medical Association Journal 2017 Jul;19(7):448-53.
2. de Boysson H, Boulouis G, Aouba A, Bienvenu B, Guillevin L, Zuber M, Touzé E, Naggara O, Pagnoux C. Adult primary angiitis of the central nervous system: isolated small-vessel vasculitis represents distinct disease pattern. Rheumatology (Oxford, England) 2017 Mar;56(3):439-44.
3. Amara AW, Bashir K, Palmer CA, Walker HC. Challenges in diagnosis of isolated central nervous system vasculitis. Brain & Behavior 2011 Sep;1(1):57-61.
4. Birnbaum J, Hellmann DB. Primary angiitis of the central nervous system. Archives of Neurology 2009 Jun;66(6):704-9.
5. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis and Rheumatism 2013 Jan;65(1):1-11.
6. Maclaren K, Gillespie J, Shrestha S, Neary D, Ballardie FW. Primary angiitis of the central nervous system: emerging variants. QJM 2005 Sep;98(9):643-54.
7. Salvarani C, Brown RD Jr, Calamia KT, Christianson TJH, Weigand SD, Miller DV, Giannini C, Meschia JF, Huston J 3rd, Hunder GG. Primary central nervous system vasculitis: analysis of 101 patients. Annals of Neurology 2007 Nov;62(5):442-51.
8. Calabrese LH, Mallek JA. Primary angiitis of the central nervous system. Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine (Baltimore) 1988 Jan;67(1):20-39.
9. Küker W, Gaertner S, Nagele T, Dopfer C, Schoning M, Fiehler J, Rothwell PM, Herrlinger U. Vessel wall contrast enhancement: a diagnostic sign of cerebral vasculitis. Cerebrovascular Diseases (Basel, Switzerland) 2008;26(1):23-9.
10. Saam T, Habs M, Pollatos O, Cyran C, Pfefferkorn T, Dichgans M, Dietrich O, Glaser C, Reiser M, Nikolauo K. High-resolution black-blood contrast-enhanced T1 weighted images for the diagnosis and follow-up of intracranial arteritis. The British Journal of Radiology 2010 Sep;83(993):e182-4.
11. Fukuma K, Kowa H, Nakayasu H, Nakashima K. Atypical arteritis in internal carotid arteries: a novel concept of isolated internal carotid arteritis. Yonago Acta Medica 2016 Sep;59(3):248-54.
12. Ivancic BD, Jovanovic I, Ljevak J, Poljakovic Z. Sixth cranial nerve palsy and ipsilateral segmental carotid arteritis after tooth alveolectomy. Neurological Sciences 2019 Sep;40(9):1975-7.
13. Ghisoni K, Martins RP, Barbeito L, Latini A. Neopterin as a potential cytoprotective brain molecule. Journal of Psychiatric Research 2015 Dec;71:134-9.
14. Viemann D, Strey A, Janning A, Jurk K, Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, Gerke V, Sorg C, Roth J. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005 Apr;105(7):2955-62.
15. Viemann D, Barczyk K, Vogl T, Fischer U, Sunderkötter C, Schulze-Osthoff K, Roth J. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood 2007 Mar;109(6):2453-60.
16. Kalashnikova LA, Dobrynina LA. Cerebral arterial dissection: ischemic stroke and other clinical manifestations. Moscow: WACO; 2013. 208 p. (In Russian).
17. Ometto F, Friso L, Astorri D, Botsios С, Raffeiner B, Punzi L, Doria A. Calprotectin in rheumatic diseases. Experimental Biology and Medicine (Maywood, N.J.) 2017;242(8):859-73.
18. Kuruto R, Nozawa R, Takeishi K, Aral K, Yokota T, Takasaki Y. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. Journal of Biochemistry 1990 Oct;108(4):650-3.
19. Soyfoo M, Roth J, Vogl T, Pochet R, Decaux G. Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus. The Journal of Rheumatology 2009 Oct;36(10):2190-4.
20. Haga H, Brun J, Berntzen H, Cervera R, Khamashta M, Hughes G. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993 Feb;2(1):247-50.
21. Lood C, Stenström M, Tydén H, Gullstrand B, Källberg E, Leanderson T, Truedsson L, Sturfelt G, Ivars F, Bengtsson AA. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Arthritis Research & Therapy 2011 Apr;13(2):R60.
22. Oktayoglu P, Mete N, Caglayan M, Bozkurt M, Bozan T, Em S, Nas K. Elevated serum levels of calprotectin (MRP8/MRP14) in patients with Behçet’s disease and its association with disease activity and quality of life. Scandinavian Journal of Clinical and Laboratory Investigation 2015 Apr;75(2):106-12.
23. Pepper RJ, Hamour S, Chavele KM, Todd SK, Rasmussen N, Flint S, Lyons PA, Smith KGC, Pusey CD, Cook HT, Salama AD. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney International 2013 Jun;83(6):1150-8.
24. Draibe JB, Pepper RJ, Merkel PA, Salama AD; RAVE-ITN Investigators. Serum calprotectin and disease relapse in ANCA-associated vasculitis. Arthritis & Rheumatology 2014 Jan;66:S818.
25. Foell D, Hernández-Rodríguez J, Sánchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. The Journal of Pathology 2004 Nov;204(3):311-6.
26. Horvath I, Jia X, Johansson P, Wang C, Moskalenko R, Steinau A, Forsgren L, Wågberg T, Svensson J, Zetterberg H, Morozova-Roche L. Pro-inflammatory S100A9 protein as a robust biomarker differentiating early stages of cognitive impairment in Alzheimer’s disease. ACS Chemical Neuroscience 2016 Jan;7(1):34-9.
27. Markowitz J, Carson WE 3rd. Review of S100A9 biology and its role in cancer. Biochimica et Biophysica Acta 2013 Jan;1835(1):100-9.
28. Ehrchen JM, Sunderkötter C, Foell D, Vogl T, Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. Journal of Leukocyte Biology 2009 Sep;86(3):557-66.
29. Pedersen SJ, Sørensen IJ, Lambert RGW, Hermann KGA, Garnero P, Johansen JS, Madsen O, Hansen A, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen KH, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Østergaard M. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor alpha inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover. Arthritis and Rheumatism 2011 Dec;63(12):3789-800.
30. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. British Journal of Rheumatology 1996 Nov;35(11):1161-8.
31. Hurnakova J, Zavada J, Hanova P, Hulejova H, Klein M, Mann H, Sleglova O, Olejarova M, Forejtova S, Ruzickova O, Komarc M, Vencovsky J, Pavelka K, Senolt L. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. Arthritis Research & Therapy 2015 Sep;17(1):252.
32. Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL, Nassonova VA, Wachter H, Fuchs D. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995 Feb;4(1):29-32.
33. Nassonov E, Samsonov M, Beketova T, Semenkova L, Wachter H, Fuchs D. Serum neopterin concentrations in Wegener’s granulomatosis correlate with vasculitis activity. Clinical and Experimental Rheumatology 1995 May-Jun;13(3):353-6.
34. Shirai R, Sato K, Yamashita T, Yamaguchi M, Okano T, Watanabe-Kominato K, Watanabe R, Matsuyama T, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Neopterin counters vascular inflammation and atherosclerosis. Journal of the American Heart Association 2018 Feb;7(3):e007359.
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]